JP2023550094A5 - - Google Patents
Info
- Publication number
- JP2023550094A5 JP2023550094A5 JP2023529970A JP2023529970A JP2023550094A5 JP 2023550094 A5 JP2023550094 A5 JP 2023550094A5 JP 2023529970 A JP2023529970 A JP 2023529970A JP 2023529970 A JP2023529970 A JP 2023529970A JP 2023550094 A5 JP2023550094 A5 JP 2023550094A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063113024P | 2020-11-12 | 2020-11-12 | |
| US63/113,024 | 2020-11-12 | ||
| PCT/US2021/059050 WO2022104002A2 (en) | 2020-11-12 | 2021-11-12 | Sars-cov-2 immunodominant peptide constructs and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023550094A JP2023550094A (ja) | 2023-11-30 |
| JP2023550094A5 true JP2023550094A5 (https=) | 2025-07-22 |
| JPWO2022104002A5 JPWO2022104002A5 (https=) | 2025-07-22 |
Family
ID=80777877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023529970A Pending JP2023550094A (ja) | 2020-11-12 | 2021-11-12 | Ｓａｒｓ－ｃｏｖ－２免疫優性ペプチドの構築物及びその使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20230398205A1 (https=) |
| EP (1) | EP4244630A4 (https=) |
| JP (1) | JP2023550094A (https=) |
| AU (3) | AU2021323389B1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115785231A (zh) * | 2021-09-10 | 2023-03-14 | 广东菲鹏生物有限公司 | 一种鉴别新冠突变型抗原的抗体、试剂及方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004031210A2 (en) * | 2002-10-03 | 2004-04-15 | Epimmune Inc. | Optimized multi-epitope constructs and uses thereof |
| ES2529736T3 (es) * | 2003-04-10 | 2015-02-25 | Novartis Vaccines And Diagnostics, Inc. | Composición inmunogénica que comprende una proteína espicular del coronavirus del SARS |
| CA2525778A1 (en) * | 2003-05-14 | 2004-12-23 | Siga Technologies, Inc. | T cell epitopes useful in a severe acute respiratory syndrome (sars) virus vaccine and as diagnostic tools and methods for identifying same |
| CA3138174A1 (en) * | 2019-05-21 | 2020-11-26 | David James O'hagan | Yeast-based oral vaccination |
| CN114502191B (zh) * | 2019-08-01 | 2026-04-03 | Acm生物实验室私人有限公司 | 通过施用具有关联的抗原的聚合物囊泡群和具有关联的佐剂的聚合物囊泡群来引发免疫应答的方法以及包含这两种聚合物囊泡群的组合物 |
| IL296617A (en) * | 2020-03-20 | 2022-11-01 | Biontech Us Inc | Vaccines against the corona virus and methods of use |
| CR20220552A (es) * | 2020-04-02 | 2023-01-17 | Regeneron Pharma | Anticuerpos contra glicoproteína de espícula anti-sars-cov-2 y fragmentos de unión al antígeno |
| EP3901261A1 (en) * | 2020-04-22 | 2021-10-27 | BioNTech RNA Pharmaceuticals GmbH | Coronavirus vaccine |
| KR20230006558A (ko) * | 2020-05-06 | 2023-01-10 | 몰리큘라 파트너스 아게 | 신규한 안키린 반복 결합 단백질 및 그의 용도 |
| CN116437951A (zh) * | 2020-05-19 | 2023-07-14 | 磨石生物公司 | Sars-cov-2疫苗 |
| CN111647054B (zh) * | 2020-06-12 | 2021-12-03 | 上海祥耀生物科技有限责任公司 | 一种用于检测新型冠状病毒SARS-CoV-2抗体的试剂及其应用 |
| US20230241205A1 (en) * | 2020-06-17 | 2023-08-03 | Tscan Therapeutics, Inc. | Sars-cov-2 immunodominant peptides and uses thereof |
| WO2022049595A1 (en) * | 2020-09-01 | 2022-03-10 | Helmholtz Zentrum für Infektionsforschung GmbH | Multi-patch vaccines and immunogenic compositions, methods of production and uses thereof |
-
2021
- 2021-11-12 AU AU2021323389A patent/AU2021323389B1/en active Active
- 2021-11-12 JP JP2023529970A patent/JP2023550094A/ja active Pending
- 2021-11-12 US US18/035,369 patent/US20230398205A1/en active Pending
- 2021-11-12 EP EP21892837.2A patent/EP4244630A4/en active Pending
-
2022
- 2022-06-21 AU AU2022204350A patent/AU2022204350B2/en active Active
-
2024
- 2024-08-14 AU AU2024205749A patent/AU2024205749A1/en active Pending